Product was Pure Bioscience’s largest product and service line in fiscal 2025, bringing in $2.20M of $2.20M (100%).
| Product and Service | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Pure Hard Surface | — | — | — | — | ||
| Product | $1.81M | $1.87M | $1.96M | $2.20M | ||
| Silverion | — | — | — | — | ||
| Royalty | $40.00K | $6.00K | $8.00K | $4.00K | ||
| Total | $1.85M | $1.88M | $1.96M | $2.20M |
Pure Bioscience brought in $2.20M from its two product and service lines in fiscal 2025, the year ended July 31, 2025. That was up 12.2% from $1.96M in fiscal 2024. Product was the largest at $2.20M (99.8%), ahead of Royalty at $4.00K (0.2%).
From fiscal 2022 to 2025, combined revenue from these lines grew from $1.85M to $2.20M, a compound annual growth rate of 5.9%. Product's share of the total rose from 97.8% to 99.8%.
Pure Bioscience (PURE) reports its revenue by product and service. In fiscal 2025, Product was its largest product and service line, bringing in $2.20M (99.8% of the total), followed by Royalty at $4.00K (0.2%).
Product was Pure Bioscience's largest product and service line in fiscal 2025, bringing in $2.20M, or 99.8% of the $2.20M total across its two product and service lines.
Every figure comes from Pure Bioscience's annual financial filings, as reported. Each line keeps the name Pure Bioscience gives it, and years follow its fiscal calendar.
Pure Bioscience's revenue by product and service goes back to fiscal 2020, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.